EC approves Sanofi and Regeneron’s Dupixent for severe asthma in children
The expanded authorisation is based on findings from the Phase III VOYAGE trial of Dupixent.
Respiratory
Latest in
Respiratory
FDA grants breakthrough therapy status to Pfizer’s RSV vaccine
RSVpreF is intended for the active vaccination of pregnant women to prevent lower respiratory tract illness linked to RSV in…
Sanofi obtains CHMP’s positive opinion for severe asthma therapy in children
The recommendation is based on data from the Phase III trial, in which Dupixent reduced the rate of severe asthma…
FDA issues complete response letter for Merck’s chronic cough treatment
The regulatory agency sought further data linked to the measurement of efficacy.
Novavax Covid-19 vaccine to be rolled out in Australia from next month
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
By
Covid-19 vaccine mixing: could heterologous boosters improve immunity?
With booster programmes underway across the globe, researchers are exploring which vaccine combinations could be most effective.
By
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patients
Vertex Pharmaceuticals’ Trikafta/Kaftrio is currently the world’s first triple-combination cystic fibrosis therapy.
By